Cell-Specific Epigenetic Drivers of Pathogenesis in Rheumatoid Arthritis

References

• Symmons D , TurnerG , WebbRet al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford)41(7), 793–800 (2002).
   PubMed Web of Science ®Google Scholar
• McInnes IB , SchettG. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med.365(23), 2205–2219 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang F , WeiK , SlowikowskiKet al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol.20(7), 928–942 (2019).
   PubMed Web of Science ®Google Scholar
• Huber LC , DistlerO , TarnerI , GayRE , GayS , PapT. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology45, 669–675 (2006).
   PubMed Web of Science ®Google Scholar
• Doorenspleet ME , KlarenbeekPL , de HairMJHet al. Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity. Ann. Rheum. Dis.73(4), 756–762 (2014).
   PubMed Web of Science ®Google Scholar
• Mulherin D , FitzgeraldO , BresnihanB. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum.39(1), 115–124 (1996).
   PubMed Web of Science ®Google Scholar
• Gizinski AM , FoxDA. T cell subsets and their role in the pathogenesis of rheumatic disease. Curr. Opin. Rheumatol.26(4), 204–210 (2014).
   PubMedGoogle Scholar
• Choy E . Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford)51(Suppl. 5), v3–v11 (2012).
   PubMed Web of Science ®Google Scholar
• Klein K , OspeltC , GayS. Epigenetic contributions in the development of rheumatoid arthritis. Arthritis Res. Ther.14(6), 227 (2012).
   PubMed Web of Science ®Google Scholar
• Kukar M , PetrynaO , EfthimiouP. Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs. Biologics3, 443–457 (2009).
   PubMedGoogle Scholar
• Plant D , WilsonAG , BartonA. Genetic and epigenetic predictors of responsiveness to treatment in RA. Nat. Rev. Rheumatol.10(6), 329–337 (2014).
   PubMed Web of Science ®Google Scholar
• Nair N , WilsonAG , BartonA. DNA methylation as a marker of response in rheumatoid arthritis. Pharmacogenomics18(14), 1323–1332 (2017).
   PubMed Web of Science ®Google Scholar
• Standish KA , HuangCC , CurranME , SchorkNJ. Comprehensive analysis of treatment response phenotypes in rheumatoid arthritis for pharmacogenetic studies. Arthritis Res. Ther.19(1), 90 (2017).
   PubMedGoogle Scholar
• Viatte S , PlantD , RaychaudhuriS. Genetics and epigenetics of rheumatoid arthritis. Nat. Rheum. Rev.9(3), 141–153 (2013).
   PubMed Web of Science ®Google Scholar
• Firestein GS . Pathogenesis of rheumatoid arthritis: the intersection of genetics and epigenetics. Trans. Am. Clin. Climatol. Assoc.129, 171–182 (2018).
   PubMedGoogle Scholar
• Okada Y , WuD , TrynkaGet al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature506(7488), 376–381 (2014).
   PubMed Web of Science ®Google Scholar
• Yarwood A , HuizingaTWJ , WorthingtonJ. The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA. Rheumatology (Oxford)55(2), 199–209 (2016).
   PubMed Web of Science ®Google Scholar
• Bottini N , FiresteinGS. Epigenetics in rheumatoid arthritis: a primer for rheumatologists. Curr. Rheumatol. Rep.15(11), 372 (2013).
   PubMed Web of Science ®Google Scholar
• Plant D , WebsterA , NairNet al. Differential methylation as a biomarker of response to etanercept in patients with rheumatoid arthritis. Arthritis Rheumatol.68(6), 1353–1360 (2016).
   PubMed Web of Science ®Google Scholar
• Nair N , PlantD , VerstappenSMet al. Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis. Rheumatology (Oxford).59)6), 1364–1371 (2019).
   Web of Science ®Google Scholar
• Karouzakis E , GayRE , GayS , NeidhartM. Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat. Rev. Rheumatol.5(5), 266–272 (2009).
   PubMed Web of Science ®Google Scholar
• Karouzakis E , RazaK , KollingCet al. Analysis of early changes in DNA methylation in synovial fibroblasts of RA patients before diagnosis. Sci. Rep.8(7370), doi:10.1038/s41598-018-24240-2 (2018).
   PubMedGoogle Scholar
• Ai R , HammakerD , BoyleDLet al. Joint-specific DNA methylation and transcriptome signatures in rheumatoid arthritis identify distinct pathogenic processes. Nat. Commun.7(1), 1–9 (2016).
   Google Scholar
• Araki Y , TsuzukiWada T , AizakiYet al. Histone methylation and STAT-3 differentially regulate interleukin-6-induced matrix metalloproteinase gene activation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheumatol.68(5), 1111–1123 (2016).
   PubMed Web of Science ®Google Scholar
• Hawtree S , MuthanaM , WilkinsonJM , AkilM , WilsonAG. Histone deacetylase 1 regulates tissue destruction in rheumatoid arthritis. Hum. Mol. Genet.24(19), 5367–5377 (2015).
   PubMed Web of Science ®Google Scholar
• Angiolilli C , KabalaPA , GrabiecAMet al. Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Ann. Rheum. Dis.76(1), 277–285 (2017).
   PubMed Web of Science ®Google Scholar
• Sohn C , LeeA , QiaoY , LoupasakisK , IvashkivLB , KallioliasGD. Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. Arthritis Rheumatol.67(1), 86–95 (2015).
   PubMed Web of Science ®Google Scholar
• Lee A , QiaoY , GrigorievGet al. Tumor necrosis factor α Induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum.65(4), 928–938 (2013).
   PubMedGoogle Scholar
• Klein K , KabalaPA , GrabiecAMet al. The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts. Ann. Rheum. Dis.75(2), 422–429 (2016).
   PubMed Web of Science ®Google Scholar
• Glossop JR , EmesRD , NixonNBet al. Genome-wide DNA methylation profiling in rheumatoid arthritis identifies disease-associated methylation changes that are distinct to individual T- and B-lymphocyte populations. Epigenetics9(9), 1228–1237 (2014).
   PubMed Web of Science ®Google Scholar
• de Andres MC , Perez-PampinE , CalazaMet al. Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate. Arthritis Res. Ther.17(1), 233 (2015).
   PubMedGoogle Scholar
• Göschl L , PreglejT , BoucheronNet al. Histone deacetylase 1 (HDAC1): a key player of T cell-mediated arthritis. J. Autoimmun.108, 102379 (2020).
   PubMed Web of Science ®Google Scholar
• Grabiec AM , KorchynskyiO , TakPP , ReedquistKA. Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. Ann. Rheum. Dis.71(3), 424–431 (2012).
   PubMed Web of Science ®Google Scholar
• Chen X , BarozziI , TermaniniAet al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc. Natl Acad. Sci. USA109(42), E2865 (2012).
   PubMed Web of Science ®Google Scholar
• Klein K , KatoM , Frank-BertonceljMet al. Evaluating the bromodomain protein BRD1 as a therapeutic target in rheumatoid arthritis. Sci. Rep.8(1), 1–7 (2018).
   PubMedGoogle Scholar
• Loh C , ParkSH , LeeA , YuanR , IvashkivLB , KallioliasGD. TNF-induced inflammatory genes escape repression in fibroblast-like synoviocytes: transcriptomic and epigenomic analysis. Ann. Rheum. Dis.78(9), 1205–1214 (2019).
   PubMed Web of Science ®Google Scholar
• Ospelt C , GayS. The role of resident synovial cells in destructive arthritis. Best Pract. Res. Clin. Rheumatol.22(2), 239–252 (2008).
   PubMed Web of Science ®Google Scholar
• Lefèvre S , KnedlaA , TennieCet al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat. Med.15(12), 1414–1420 (2009).
   PubMed Web of Science ®Google Scholar
• Lee A , QiaoY , GrigorievGet al. Tumor necrosis factor α Induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum.65(4), 928–938 (2013).
   PubMedGoogle Scholar
• Loupasakis K , KuoD , SokhiUKet al. Tumor necrosis factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol.67(1), 86–95 (2017).
   Google Scholar
• The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell. Mol. Biol. Lett.10(4), 631–647 (2005).
   PubMed Web of Science ®Google Scholar
• Liu Y , AryeeMJ , PadyukovLet al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat. Biotechnol.31(2), 142–147 (2013).
   PubMed Web of Science ®Google Scholar
• Liu C-C , FangT-J , OuT-Tet al. Global DNA methylation, DNMT1, and MBD2 in patients with rheumatoid arthritis. Immunol. Lett.135(1), 96–99 (2011).
   PubMed Web of Science ®Google Scholar
• Shao X , HudsonM , ColmegnaIet al. Rheumatoid arthritis-relevant DNA methylation changes identified in ACPA-positive asymptomatic individuals using methylome capture sequencing. Clin. Epigenetics11(1), 110 (2019).
   PubMedGoogle Scholar
• Pitaksalee R , BurskaAN , AjaibSet al. Differential CpG DNA methylation in peripheral naïve CD4+ T-cells in early rheumatoid arthritis patients. Clin. Epigenetics12(1), 54 (2020).
   PubMed Web of Science ®Google Scholar
• Karouzakis E , GayRE , MichelBA , GayS , NeidhartM. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum.60(12), 3613–3622 (2009).
   PubMed Web of Science ®Google Scholar
• Nakano K , BoyleDL , FiresteinGS. Regulation of DNA methylation in rheumatoid arthritis synoviocytes. J. Immunol.190(3), 1297–1303 (2013).
   PubMed Web of Science ®Google Scholar
• Nakano K , WhitakerJW , BoyleDL , WangW , FiresteinGS. DNA methylome signature in rheumatoid arthritis. Ann. Rheum. Dis.72(1), 110–117 (2013).
   PubMed Web of Science ®Google Scholar
• Ai R , WhitakerJW , BoyleDLet al. DNA methylome signature in early rheumatoid arthritis synoviocytes compared with longstanding rheumatoid arthritis synoviocytes. Arthritis Rheumatol.67(7), 1978–1980 (2015).
   PubMed Web of Science ®Google Scholar
• Frank-Bertoncelj M , TrenkmannM , KleinKet al. Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions. Nat. Commun.8(1), 1–14 (2017).
   PubMedGoogle Scholar
• Dong X , WengZ. The correlation between histone modifications and gene expression. Epigenomics5(2), 113–116 (2013).
   PubMed Web of Science ®Google Scholar
• Eberharter A , BeckerPB. Histone acetylation: a switch between repressive and permissive chromatin: second in review series on chromatin dynamics. EMBO Rep.3(3), 224 (2002).
   PubMed Web of Science ®Google Scholar
• Wada TT , ArakiY , SatoKet al. Aberrant histone acetylation contributes to elevated interleukin-6 production in rheumatoid arthritis synovial fibroblasts. Biochem. Biophys. Res. Commun.444(4), 682–686 (2014).
   PubMed Web of Science ®Google Scholar
• Rengel Y , OspeltC , GayS. Proteinases in the joint: clinical relevance of proteinases in joint destruction. Arthritis. Res. Ther.9(5), 221 (2007).
   PubMed Web of Science ®Google Scholar
• Green MJ , GoughAKS , DevlinJet al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology42(1), 83–88 (2003).
   PubMed Web of Science ®Google Scholar
• Shinozaki M , InoueE , NakajimaAet al. Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA. Mod. Rheumatol.17(5), 403–408 (2007).
   PubMedGoogle Scholar
• Ai R , LaragioneT , HammakerDet al. Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes. Nat. Commun.9(1921), doi:10.1038/s41467-018-04310-9 (2018).
   Google Scholar
• Yap H-Y , TeeS , WongM , ChowS-K , PehS-C , TeowS-Y. Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development. Cells7(10), 161 (2018).
   PubMed Web of Science ®Google Scholar
• Ishida K , KobayashiT , ItoSet al. Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. J. Periodontol.83(7), 917–925 (2012).
   PubMed Web of Science ®Google Scholar
• Nile CJ , ReadRC , AkilM , DuffGW , WilsonAG. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum.58(9), 2686–2693 (2008).
   PubMedGoogle Scholar
• Clark AD , NairN , AndersonAEet al. Lymphocyte DNA methylation mediates genetic risk at shared immune-mediated disease loci. J. Allergy Clin. Immunol.145, 1438–1451 (2020).
   PubMed Web of Science ®Google Scholar
• Grabiec AM , KrauszS , de JagerWet al. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J. Immunol.184(5), 2718–2728 (2010).
   PubMed Web of Science ®Google Scholar
• Gillespie J , SavicS , WongCet al. Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Rheum.64(2), 418–422 (2012).
   PubMedGoogle Scholar
• Li Y , ZhouM , LvXet al. Reduced activity of HDAC3 and increased acetylation of histones H3 in peripheral blood mononuclear cells of patients with rheumatoid arthritis. J. Immunol. Res.2018, 7313515 (2018) doi:https://doi.org/10.1155/2018/7313515.
   PubMed Web of Science ®Google Scholar
• Sever R , GlassCK. Signaling by nuclear receptors. Cold Spring Harb. Perspect. Biol.5(3), doi:10.1101/cshperspect.a016709, a016709 (2013).
   PubMed Web of Science ®Google Scholar
• LeRoy G , RickardsB , FlintSJ. The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol. Cell30(1), 51–60 (2008).
   PubMed Web of Science ®Google Scholar
• Moon KJ , MochizukiK , ZhouM , JeongHS , BradyJN , OzatoK. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell19(4), 523–534 (2005).
   PubMed Web of Science ®Google Scholar
• Tough DF , PrinjhaRK , TakPP. Epigenetic mechanisms and drug discovery in rheumatology. Clin. Med.15(6), S64–S71 (2015).
   PubMedGoogle Scholar
• Nicodeme E , JeffreyKL , SchaeferUet al. Suppression of inflammation by a synthetic histone mimic. Nature468(7327), 1119–1123 (2010).
   PubMed Web of Science ®Google Scholar
• Dawson MA , PrinjhaRK , DittmannAet al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature478(7370), 529–533 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang QG , QianJ , ZhuYC. Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis. Immunol. Lett.166(2), 103–108 (2015).
   PubMed Web of Science ®Google Scholar
• Krishna V , YinX , SongQet al. Integration of the transcriptome and genome-wide landscape of BRD2 and BRD4 binding motifs identifies key superenhancer genes and reveals the mechanism of bet inhibitor action in rheumatoid arthritis synovial fibroblasts. J. Immunol.206(2), 422–431 (2021).
   PubMed Web of Science ®Google Scholar
• Houseman EA , MolitorJ , MarsitCJ. Reference-free cell mixture adjustments in analysis of DNA methylation data. Bioinformatics30(10), 1431–1439 (2014).
   PubMed Web of Science ®Google Scholar
• Andersson R , GebhardC , Miguel-EscaladaIet al. An atlas of active enhancers across human cell types and tissues. Nature507(7493), 455–461 (2014).
   PubMed Web of Science ®Google Scholar
• Hnisz D , AbrahamBJ , LeeTIet al. Super-enhancers in the control of cell identity and disease. Cell155(4), 934–947 (2013).
   PubMed Web of Science ®Google Scholar
• Yamagata K , NakayamadaS , TanakaY. Critical roles of super-enhancers in the pathogenesis of autoimmune diseases. Nat. Rev. Rheum.9(3), 141–153 (2020).
   Google Scholar
• Farh KKH , MarsonA , ZhuJet al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature518(7539), 337–343 (2015).
   PubMed Web of Science ®Google Scholar
• Vahedi G , KannoY , FurumotoYet al. Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature520(7548), 558–562 (2015).
   PubMed Web of Science ®Google Scholar
• Ellis JA , MunroJE , ChavezRAet al. Genome-scale case-control analysis of CD4+ T-cell DNA methylation in juvenile idiopathic arthritis reveals potential targets involved in disease. Clin. Epigenetics4(1), 20 (2012).
   PubMed Web of Science ®Google Scholar
• Leenen FAD , MullerCP , TurnerJDet al. DNA methylation: conducting the orchestra from exposure to phenotype? Clin. Epigenetics 8(1), 92 (2016).
   PubMedGoogle Scholar
• Van Dongen J , NivardMG , WillemsenGet al. Genetic and environmental influences interact with age and sex in shaping the human methylome. Nat. Commun.7(11115), doi:10.1038/ncomms11115 (2016).
   Google Scholar
• Meng W , ZhuZ , JiangXet al. DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis. Arthritis Res. Ther.19(1), 71 (2017).
   PubMedGoogle Scholar
• Ince-Askan H , MandaviyaPR , FelixJFet al. Altered DNA methylation in children born to mothers with rheumatoid arthritis during pregnancy. Ann. Rheum. Dis.78(9), 1198–1204 (2019).
   PubMed Web of Science ®Google Scholar